116 related articles for article (PubMed ID: 26507218)
21. Synthesis of the fused polyether core of hemibrevetoxin B by two-directional ring-closing metathesis.
Clark JS; Grainger DM; Ehkirch AA; Blake AJ; Wilson C
Org Lett; 2007 Mar; 9(6):1033-6. PubMed ID: 17311391
[TBL] [Abstract][Full Text] [Related]
22. Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kinases (CDKs), Janus kinase 2 (JAK2), and fms-like tyrosine kinase-3 (FLT3) for the treatment of cancer.
William AD; Lee AC; Goh KC; Blanchard S; Poulsen A; Teo EL; Nagaraj H; Lee CP; Wang H; Williams M; Sun ET; Hu C; Jayaraman R; Pasha MK; Ethirajulu K; Wood JM; Dymock BW
J Med Chem; 2012 Jan; 55(1):169-96. PubMed ID: 22148278
[TBL] [Abstract][Full Text] [Related]
23. Pacritinib Bests Available Therapies for Myelofibrosis.
Cancer Discov; 2015 Jul; 5(7):OF7. PubMed ID: 26034055
[No Abstract] [Full Text] [Related]
24. Cascade Metathesis Reactions for the Synthesis of Taxane and Isotaxane Derivatives.
Ma C; Letort A; Aouzal R; Wilkes A; Maiti G; Farrugia LJ; Ricard L; Prunet J
Chemistry; 2016 May; 22(20):6891-8. PubMed ID: 27062670
[TBL] [Abstract][Full Text] [Related]
25. Toward an enantioselective total synthesis of sarain A: construction of an advanced intermediate and rearrangement of the sarain A core under mild conditions.
Douglas CJ; Hiebert S; Overman LE
Org Lett; 2005 Mar; 7(5):933-6. PubMed ID: 15727478
[TBL] [Abstract][Full Text] [Related]
26. Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors.
Shaaban MR; Saleh TS; Mayhoub AS; Farag AM
Eur J Med Chem; 2011 Sep; 46(9):3690-5. PubMed ID: 21664013
[TBL] [Abstract][Full Text] [Related]
27. Total Synthesis of (+)-Fusarisetin A Driven by a One-Pot Four-Reaction Process.
Liu C; Zeng Z; Chen R; Jiang X; Wang Y; Zhang Y
Org Lett; 2016 Feb; 18(3):624-7. PubMed ID: 26812626
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines.
Schenone S; Brullo C; Bruno O; Bondavalli F; Mosti L; Maga G; Crespan E; Carraro F; Manetti F; Tintori C; Botta M
Eur J Med Chem; 2008 Dec; 43(12):2665-76. PubMed ID: 18342402
[TBL] [Abstract][Full Text] [Related]
29. Discovery of the macrocycle (9E)-15-(2-(pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a potent inhibitor of janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) for the treatment of rheumatoid arthritis.
William AD; Lee AC; Poulsen A; Goh KC; Madan B; Hart S; Tan E; Wang H; Nagaraj H; Chen D; Lee CP; Sun ET; Jayaraman R; Pasha MK; Ethirajulu K; Wood JM; Dymock BW
J Med Chem; 2012 Mar; 55(6):2623-40. PubMed ID: 22339472
[TBL] [Abstract][Full Text] [Related]
30. Stereoselective synthesis of configurationally stable functionalized ethano-bridged Tröger bases.
Michon C; Sharma A; Bernardinelli G; Francotte E; Lacour J
Chem Commun (Camb); 2010 Apr; 46(13):2206-8. PubMed ID: 20234907
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of the tetracyclic ABCD ring systems of madangamines D-F.
Diaba F; Pujol-Grau C; Martínez-Laporta A; Fernández I; Bonjoch J
Org Lett; 2015 Feb; 17(3):568-71. PubMed ID: 25607252
[TBL] [Abstract][Full Text] [Related]
32. Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).
Burns CJ; Bourke DG; Andrau L; Bu X; Charman SA; Donohue AC; Fantino E; Farrugia M; Feutrill JT; Joffe M; Kling MR; Kurek M; Nero TL; Nguyen T; Palmer JT; Phillips I; Shackleford DM; Sikanyika H; Styles M; Su S; Treutlein H; Zeng J; Wilks AF
Bioorg Med Chem Lett; 2009 Oct; 19(20):5887-92. PubMed ID: 19762238
[TBL] [Abstract][Full Text] [Related]
33. Synthesizing the tetracyclic core of nanolobatolide.
Chang L; Jiang H; Fu J; Liu B; Li CC; Yang Z
J Org Chem; 2012 Apr; 77(7):3609-14. PubMed ID: 22414060
[TBL] [Abstract][Full Text] [Related]
34. Studies on the synthesis of the ABC rings of (+/-)-hexacyclinic acid.
Clarke PA; Cridland AP; Rolla GA; Iqbal M; Bainbridge NP; Whitwood AC; Wilson C
J Org Chem; 2009 Oct; 74(20):7812-21. PubMed ID: 19813768
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of diazatricyclic common structure of madangamine alkaloids.
Yanagita Y; Suto T; Matsuo N; Kurosu Y; Sato T; Chida N
Org Lett; 2015 Apr; 17(8):1946-9. PubMed ID: 25815528
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel, potent and selective inhibitors of Polo-like kinase 1.
Chen S; Bartkovitz D; Cai J; Chen Y; Chen Z; Chu XJ; Le K; Le NT; Luk KC; Mischke S; Naderi-Oboodi G; Boylan JF; Nevins T; Qing W; Chen Y; Wovkulich PM
Bioorg Med Chem Lett; 2012 Jan; 22(2):1247-50. PubMed ID: 22172702
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Rondelli D
Haematologica; 2008 Oct; 93(10):1449-50. PubMed ID: 18827262
[No Abstract] [Full Text] [Related]
38. Five-membered heteroaromatic ring fused-pyrimidine derivatives: design, synthesis, and hedgehog signaling pathway inhibition study.
Zhang L; Xin M; Shen H; Wen J; Tang F; Tu C; Zhao X; Wei P
Bioorg Med Chem Lett; 2014 Aug; 24(15):3486-92. PubMed ID: 24923765
[TBL] [Abstract][Full Text] [Related]
39. Total synthesis and biological evaluation of atrop-O-benzyl-desmethylabyssomicin C.
Matovic R; Bihelovic F; Gruden-Pavlovic M; Saicic RN
Org Biomol Chem; 2014 Oct; 12(39):7682-5. PubMed ID: 25166901
[TBL] [Abstract][Full Text] [Related]
40. First diastereoselective chiral synthesis of (-)-securinine.
Honda T; Namiki H; Kaneda K; Mizutani H
Org Lett; 2004 Jan; 6(1):87-9. PubMed ID: 14703357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]